Log In
Print
BCIQ
Print
Print this Print this
 

KB001-A

  Manage Alerts
Collapse Summary General Information
Company KaloBios Pharmaceuticals Inc.
DescriptionHumanized antibody fragment against PcrV (V-antigen) on Pseudomonas aeruginosa
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today